Clayton

Clayton Biotechnologies is a Houston-based biotechnology company that facilitates the commercialization of medical research discoveries made by the Clayton Foundation for Medical Research and its associated investigators. The company acts as a bridge between academic research and the pharmaceutical industry, managing a diverse portfolio of intellectual property across oncology, cardiovascular, and metabolic diseases. Clayton Biotechnologies focuses on licensing its technologies to established pharmaceutical companies or spinning off new startup ventures to advance therapeutic and diagnostic candidates through clinical development. Their portfolio includes a variety of modalities, ranging from small molecules to biologics and vaccines.